USP strives to advance quality throughout the public health framework with standards.
USP strives to advance quality throughout the public health framework with standards. Safeguarding the integrity of the global supply chain end-to-end is fundamental to protecting the public’s health, especially as products come from all over the world.
Manufacturers must ensure the purity and quality of the biologics that make their way to patients. USP is a global leader in the development of quality standards for biologics that assist manufacturers by increasing predictability and reliability, and preserving the integrity of the global supply chain.
USP
12601 Twinbrook Pkwy, Rockville, MD 20852
custsvc@usp.org
tel. 800. 227.8772
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
Novel Modalities Spur Shift in Outsourcing Processes and Partnerships
May 8th 2025While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as transactional relationships, but true partners with a common goal of getting drugs to patients faster.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.